日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ZNFX1 Functions as a Master Regulator of Epigenetically Induced Pathogen Mimicry and Inflammasome Signaling in Cancer.

ZNFX1 在癌症中作为表观遗传诱导的病原体模拟和炎症小体信号传导的主调节因子发挥作用

Stojanovic Lora, Abbotts Rachel, Tripathi Kaushelendra, Coon Collin M, Rajendran Saranya, Abbasi Farid Elnaz, Hostetter Galen, Guarnieri Joseph W, Wallace Douglas C, Liu Sheng, Wan Jun, Calendo Gennaro, Marker Rebecca, Gohari Zahra, Inayatullah Mohammed M A, Tiwari Vijay K, Kader Tanjina, Santagata Sandro, Drapkin Ronny, Kommoss Stefan, Pfisterer Jacobus, Konecny Gottfried E, Coopergard Ryan, Issa Jean-Pierre J, Winterhoff Boris J N, Topper Michael J, Sandusky George E, Miller Kathy D, Baylin Stephen B, Nephew Kenneth P, Rassool Feyruz V

Phase 3 clinical trials evaluating poly(ADP-ribose) polymerase inhibition plus immunotherapy for first-line treatment of advanced ovarian cancer

评估聚(ADP-核糖)聚合酶抑制剂联合免疫疗法一线治疗晚期卵巢癌的3期临床试验

Rimel, B J; Pujade-Lauraine, Eric; Moore, Kathleen; Pfisterer, Jacobus; Han, Sileny; Cibula, David; Reyners, Anna; Redondo, Andrés; Papadimitriou, Christos; Eitan, Ram; Pignata, Sandro; Glasspool, Rosalind; Mirza, Mansoor Raza; Bodnar, Lubomir; Duska, Linda; Provencher, Diane; Phaëton, Rébécca; Bains, Manjinder; Coskuncay, Elif; Hardy-Bessard, Anne Claire

Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease

对接受初次肿瘤细胞减灭术的卵巢癌患者进行全基因组关联分析,可识别与残留疾病相关的候选基因。

Ramachandran, Dhanya; Tyrer, Jonathan P; Kommoss, Stefan; DeFazio, Anna; Riggan, Marjorie J; Webb, Penelope M; Fasching, Peter A; Lambrechts, Diether; García, María J; Rodríguez-Antona, Cristina; Goodman, Marc T; Modugno, Francesmary; Moysich, Kirsten B; Karlan, Beth Y; Lester, Jenny; Kjaer, Susanne K; Jensen, Allan; Høgdall, Estrid; Goode, Ellen L; Cliby, William A; Kumar, Amanika; Wang, Chen; Cunningham, Julie M; Winham, Stacey J; Monteiro, Alvaro N; Schildkraut, Joellen M; Cramer, Daniel W; Terry, Kathryn L; Titus, Linda; Bjorge, Line; Thomsen, Liv Cecilie Vestrheim; Pejovic, Tanja; Høgdall, Claus K; McNeish, Iain A; May, Taymaa; Huntsman, David G; Pfisterer, Jacobus; Canzler, Ulrich; Park-Simon, Tjoung-Won; Schröder, Willibald; Belau, Antje; Hanker, Lars; Harter, Philipp; Sehouli, Jalid; Kimmig, Rainer; de Gregorio, Nikolaus; Schmalfeldt, Barbara; Baumann, Klaus; Hilpert, Felix; Burges, Alexander; Winterhoff, Boris; Schürmann, Peter; Speith, Lisa-Marie; Hillemanns, Peter; Berchuck, Andrew; Johnatty, Sharon E; Ramus, Susan J; Chenevix-Trench, Georgia; Pharoah, Paul D P; Dörk, Thilo; Heitz, Florian

Low probability of disease cure in advanced ovarian carcinomas before the PARP inhibitor era

在PARP抑制剂时代之前,晚期卵巢癌的治愈率很低。

You, Benoit; Van Wagensveld, Lilian; Tod, Michel; Sonke, Gabe S; Horlings, Hugo M; Kruitwagen, R F P M; Du Bois, Andreas; Selle, Frédéric; Perren, Timothy; Pfisterer, Jacobus; Joly, Florence; Cook, Adrian; Kaminsky, Marie Christine; Wollschlaeger, Kerstin; Lortholary, Alain; Tome, Oliver; Leary, Alexandra; Freyer, Gilles; Van Der Aa, Maaike; Colomban, Olivier

Dilution of Molecular-Pathologic Gene Signatures by Medically Associated Factors Might Prevent Prediction of Resection Status After Debulking Surgery in Patients With Advanced Ovarian Cancer

医学相关因素对分子病理基因特征的稀释可能妨碍对晚期卵巢癌患者减瘤手术后切除状态的预测

Heitz, Florian; Kommoss, Stefan; Tourani, Roshan; Grandelis, Anthony; Uppendahl, Locke; Aliferis, Constantin; Burges, Alexander; Wang, Chen; Canzler, Ulrich; Wang, Jinhua; Belau, Antje; Prader, Sonia; Hanker, Lars; Ma, Sisi; Ataseven, Beyhan; Hilpert, Felix; Schneider, Stephanie; Sehouli, Jalid; Kimmig, Rainer; Kurzeder, Christian; Schmalfeldt, Barbara; Braicu, Elena I; Harter, Philipp; Dowdy, Sean C; Winterhoff, Boris J; Pfisterer, Jacobus; du Bois, Andreas

Pelvic Lymphadenectomy in Vulvar Cancer - Does it make sense?

外阴癌患者行盆腔淋巴结切除术——这样做有意义吗?

Woelber, Linn; Bommert, Mareike; Prieske, Katharina; Fischer, Inger; Zu Eulenburg, Christine; Vettorazzi, Eik; Harter, Philipp; Jueckstock, Julia; Hilpert, Felix; de Gregorio, Niko; Iborra, Severine; Sehouli, Jalid; Ignatov, Atanas; Hillemanns, Peter; Fuerst, Sophie; Strauss, Hans-Georg; Baumann, Klaus; Beckmann, Matthias; Mustea, Alexander; Meier, Werner; Wimberger, Pauline; Hanker, Lars; Canzler, Ulrich; Fehm, Tanja; Luyten, Alexander; Hellriegel, Martin; Kosse, Jens; Heiss, Christoph; Hantschmann, Peer; Mallmann, Peter; Tanner, Berno; Pfisterer, Jacobus; Mahner, Sven; Schmalfeldt, Barbara; Jaeger, Anna

Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer

在ICON7试验中,根据分期和/或残留病灶对新诊断的卵巢癌患者进行卡铂和紫杉醇联合或不联合贝伐珠单抗治疗的探索性结果分析

González Martín, Antonio; Oza, Amit M; Embleton, Andrew C; Pfisterer, Jacobus; Ledermann, Jonathan A; Pujade-Lauraine, Eric; Kristensen, Gunnar; Bertrand, Monique A; Beale, Philip; Cervantes, Andrés; Kent, Emma; Kaplan, Richard S; Parmar, Mahesh K B; Scotto, Nana; Perren, Timothy J

Tubo-Ovarian Transitional Cell Carcinoma and High-grade Serous Carcinoma Show Subtly Different Immunohistochemistry Profiles

输卵管卵巢移行细胞癌和高级别浆液性癌的免疫组织化学特征略有不同

Magrill, Jamie; Karnezis, Anthony N; Tessier-Cloutier, Basile; Talhouk, Aline; Kommoss, Stefan; Cochrane, Dawn; Chow, Christine; Cheng, Angela; Soslow, Robert; Hauptmann, Steffen; du Bois, Andreas; Pfisterer, Jacobus; Gilks, C Blake; Huntsman, David G; Kommoss, Friedrich

Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1)

连续卵巢癌患者中包括 BRCA1/2 在内的风险基因中有害种系变异的患病率 (AGO-TR-1)

Harter, Philipp; Hauke, Jan; Heitz, Florian; Reuss, Alexander; Kommoss, Stefan; Marmé, Frederik; Heimbach, André; Prieske, Katharina; Richters, Lisa; Burges, Alexander; Neidhardt, Guido; de Gregorio, Nikolaus; El-Balat, Ahmed; Hilpert, Felix; Meier, Werner; Kimmig, Rainer; Kast, Karin; Sehouli, Jalid; Baumann, Klaus; Jackisch, Christian; Park-Simon, Tjoung-Won; Hanker, Lars; Kröber, Sandra; Pfisterer, Jacobus; Gevensleben, Heidrun; Schnelzer, Andreas; Dietrich, Dimo; Neunhöffer, Tanja; Krockenberger, Mathias; Brucker, Sara Y; Nürnberg, Peter; Thiele, Holger; Altmüller, Janine; Lamla, Josefin; Elser, Gabriele; du Bois, Andreas; Hahnen, Eric; Schmutzler, Rita

Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci.

对与卵巢癌生存相关的种系变异的分析,确定了 1q22 和 19p12 结果位点的功能候选基因。

Glubb Dylan M, Johnatty Sharon E, Quinn Michael C J, O'Mara Tracy A, Tyrer Jonathan P, Gao Bo, Fasching Peter A, Beckmann Matthias W, Lambrechts Diether, Vergote Ignace, Velez Edwards Digna R, Beeghly-Fadiel Alicia, Benitez Javier, Garcia Maria J, Goodman Marc T, Thompson Pamela J, Dörk Thilo, Dürst Matthias, Modungo Francesmary, Moysich Kirsten, Heitz Florian, du Bois Andreas, Pfisterer Jacobus, Hillemanns Peter, Karlan Beth Y, Lester Jenny, Goode Ellen L, Cunningham Julie M, Winham Stacey J, Larson Melissa C, McCauley Bryan M, Kjær Susanne Krüger, Jensen Allan, Schildkraut Joellen M, Berchuck Andrew, Cramer Daniel W, Terry Kathryn L, Salvesen Helga B, Bjorge Line, Webb Penny M, Grant Peter, Pejovic Tanja, Moffitt Melissa, Hogdall Claus K, Hogdall Estrid, Paul James, Glasspool Rosalind, Bernardini Marcus, Tone Alicia, Huntsman David, Woo Michelle, Group Aocs, deFazio Anna, Kennedy Catherine J, Pharoah Paul D P, MacGregor Stuart, Chenevix-Trench Georgia